{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:41:42Z","timestamp":1792456902735,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R21 AI164578"],"award-info":[{"award-number":["R21 AI164578"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118373","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:58:45Z","timestamp":1763762325000},"page":"118373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivatives"],"prefix":"10.1016","volume":"302","author":[{"given":"Soumitra","family":"Guin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Alden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Harshbarger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie C.","family":"Ristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Jezewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian J.","family":"Krysan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5484-619X","authenticated-orcid":false,"given":"Marvin J.","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.118373_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118373_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2017.1328279","article-title":"Drug development challenges and strategies to address emerging and resistant fungal pathogens","volume":"15","author":"McCarthy","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118373_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40249-023-01073-4","article-title":"Cryptococcus neoformans, a global threat to human health","volume":"12","author":"Zhao","year":"2023","journal-title":"Infect. Dis. Poverty"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118373_bib4","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1038\/s41598-019-43941-w","article-title":"Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study","volume":"9","author":"Hurtado","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118373_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41579-023-00960-9","article-title":"The rapid emergence of antifungal-resistant human-pathogenic fungi","volume":"21","author":"Lockhart","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118373_bib6","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41579-021-00511-0","article-title":"Treatment strategies for cryptococcal infection: challenges, advances and future outlook","volume":"19","author":"Iyer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118373_bib7","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S1473-3099(18)30493-6","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries","volume":"19","author":"Loyse","year":"2019","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118373_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/AAC.31.5.834","article-title":"Activity of phenothiazines against medically important yeasts","volume":"31","author":"Eilam","year":"1987","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.ejmech.2025.118373_bib9","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1111\/j.1439-0507.2010.02010.x","article-title":"In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species","volume":"54","author":"Galg\u00f3czy","year":"2011","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118373_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2010.10.019","article-title":"Synthesis and antifungal activity of some substituted phenothiazines and related compounds","volume":"46","author":"Sarmiento","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118373_bib11","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis","volume":"12","author":"Butts","year":"2013","journal-title":"Eukaryot. Cell"},{"issue":"4","key":"10.1016\/j.ejmech.2025.118373_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acsinfecdis.7b00157","article-title":"Antifungal phenothiazines: optimization, characterization of mechanism, and modulation of neuroreceptor activity","volume":"4","author":"Montoya","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118373_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00567-23","article-title":"CWHM-974 is a fluphenazine derivative with improved antifungal activity against Candida albicans due to reduced susceptibility to multidrug transporter-mediated resistance mechanisms","volume":"67","author":"Miron-Ocampo","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.ejmech.2025.118373_bib14","first-page":"18347","article-title":"Antifungal structure-activity relationship studies of broad-spectrum phenothiazines","volume":"10","author":"Brosend","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118373_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107498","article-title":"Benzo[a]phenoxazine derivative C34 efficacy against fluconazole-resistant Candida spp","volume":"203","author":"Pacheco","year":"2025","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118373_bib16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2174\/1389557520666201214102151","article-title":"Medicinal and biological significance of phenoxazine derivatives","volume":"21","author":"Shukla","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"issue":"36","key":"10.1016\/j.ejmech.2025.118373_bib17","doi-asserted-by":"crossref","first-page":"31924","DOI":"10.1074\/jbc.M507057200","article-title":"Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling","volume":"280","author":"Thimmaiah","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.118373_bib18","doi-asserted-by":"crossref","first-page":"10523","DOI":"10.1021\/acs.joc.7b02025","article-title":"Phenoxazine: a privileged scaffold for radical-trapping antioxidants","volume":"82","author":"Farmer","year":"2017","journal-title":"J. Org. Chem."},{"issue":"75","key":"10.1016\/j.ejmech.2025.118373_bib19","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1039\/C4CC05376A","article-title":"Cu-catalyzed Suzuki-Miyaura reactions of primary and secondary benzyl halides with arylboronates","volume":"50","author":"Sun","year":"2014","journal-title":"Chem. Commun."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118373_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00081-23","article-title":"Novel keto-alkyl-pyridinium antifungal molecules active in models of in vivo Candida albicans vascular catheter infection and Ex vivo Candida auris skin colonization","volume":"67","author":"Beattie","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20","key":"10.1016\/j.ejmech.2025.118373_bib21","doi-asserted-by":"crossref","first-page":"11085","DOI":"10.1073\/pnas.1920154117","article-title":"The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma","volume":"117","author":"Bhat","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3\u20134","key":"10.1016\/j.ejmech.2025.118373_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drudis.2011.01.001","article-title":"Phenothiazine: the seven lives of pharmacology's first lead structure","volume":"16","author":"Ohlow","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"7428","key":"10.1016\/j.ejmech.2025.118373_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118373_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1295185","article-title":"The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition","volume":"13","author":"Vanneste","year":"2023","journal-title":"Front. Oncol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:01:33Z","timestamp":1773831693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"alternative-id":["S0223523425011389"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118373","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second generation repurposing of phenothiazine antipsychotic drugs as antifungal lead molecules via optimization of phenoxazine derivatives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118373"}}